Miniaturized label-free smartphone assisted electrochemical sensing approach for personalized COVID-19 diagnosis

被引：51

作者：

Chandra P. ^{[1
]}

机构：

[1] Laboratory of Bio-Physio Sensors and Nanobioengineering, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Uttar Pradesh, Varanasi

来源：

Sensors International | 2020年 / 1卷

关键词：

Biosensors; Coronavirus; COVID-19; Personalized diagnosis; Smart phone;

D O I：

10.1016/j.sintl.2020.100019

中图分类号：

学科分类号：

摘要：

The COVID-19, coronavirus disease is an infectious disease caused by a novel virus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). By March 2020 the novel coronavirus known to cause a pandemic has infected nearly about 119 thousand people and killed more than 4,300 around 114 countries. Apart from the current controversial opinions about the origin, spreading, and sociological impact, it is much more imperative to put a halt to this current situation. Understanding, testing, and early to rapid diagnosis may be now the only key that can contain COVID-19 by “flattening the curve”. Biosensing is the platform that allows rapid, highly sensitive, and selective detection of analytes which in turn can serve the purpose for fast and precise detection of COVID-19. In this article, based on recently reported miniaturized sensing strategies, we hereby propose a promising personalized smartphone assisted electrochemical sensing platform for diagnosis of COVID-19. © 2020 The Author

引用

共 39 条

[1]

WHO, Q&A on Coronaviruses (COVID-19), (2020)

[2]

Worldometer, Coronavirus Update (Live): 472,907 Cases and 21,315 Deaths from COVID-19 Virus Outbreak - Worldometer, (2020)

[3]

Shetti N.P., Srivastava R.K., Sharma S., Basu S., Aminabhavi T.M., Invasion of novel corona virus ( COVID-19) in Indian territory, Sensors Int, 1, (2020)

[4]

Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W., A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., (2020)

[5]

Sharma S., Basu S., Shetti N.P., Aminabhavi T.M., Current treatment protocol for COVID-19 in India, Sensors Int, 1, (2020)

[6]

Li Z., Yi Y., Luo X., Xiong N., Liu Y., Li S., Sun R., Wang Y., Hu B., Chen W., Zhang Y., Wang J., Huang B., Lin Y., Yang J., Cai W., Wang X., Cheng J., Chen Z., Sun K., Pan W., Zhan Z., Chen L., Ye F., Development and clinical application of A rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis, J. Med. Virol., (2020)

[7]

Vashist S.K., In Vitro Diagnostic Assays for COVID-19 : Recent Advances and Emerging Trends, (2020)

[8]

Dai W., Zhang H., Yu J., Xu H., Chen H., Luo S., Zhang H., Liang L., Wu X., Lei Y., Lin F., CT imaging and differential diagnosis of COVID-19, Can. Assoc. Radiol. J., (2020)

[9]

Mahapatra S., Chandra P., Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis, Biosens. Bioelectron., (2020)

[10]

Bai H.X., Hsieh B., Xiong Z., Halsey K., Choi J.W., Tran T.M.L., Pan I., Shi L.-B., Wang D.-C., Mei J., Jiang X.-L., Zeng Q.-H., Egglin T.K., Hu P.-F., Agarwal S., Xie F., Li S., Healey T., Atalay M.K., Liao W.-H., Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT, Radiology, (2020)

← 1 2 3 4 →